Sensitization of tumours to immunotherapy by boosting early type-I interferon responses enables epitope spreading
{{output}}
The success of cancer immunotherapies is predicated on the targeting of highly expressed neoepitopes, which preferentially favours malignancies with high mutational burden. Here we show that early responses by type-I interferons mediate the success of immune c... ...
